GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (OTCPK:HBPCF) » Definitions » Price-to-Funds-From-Operations

HBPCF (Helix BioPharma) Price-to-Funds-From-Operations : (As of Mar. 25, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Helix BioPharma Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Helix BioPharma Business Description

Traded in Other Exchanges
Address
40 Temperance Street, Suite 2700, Bay Adelaide Centre - North Tower, Toronto, ON, CAN, M5H0B4
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidate is L-DOS47 for Tumor Defence Breaker is in clinical trials for pancreatic cancer.